Cuba vs Libya: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Cuba
21.5%
in 2021
Libya
21.4%
in 2021
Cuba rank
87th
Libya rank
88th
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Cuba
- Libya
How they compare
Cuba currently reports 21.5% against 21.4% in Libya, a difference of 0.1%.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Libya ahead.
Cuba ranks 87th and Libya ranks 88th of 185 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.7% | 21.8% | 2.1% | Libya |
| 2010s | 19.5% | 21.7% | 2.2% | Libya |
| 2020s | 20.9% | 22.2% | 1.3% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Cuba or Libya?
- Cuba, at 21.5% against 21.4% in Libya as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Cuba and Libya?
- 0.1%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Libya?
- 22 years are reported by both, from 2000 to 2021.
- How do Cuba and Libya rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Cuba ranks 87th and Libya ranks 88th of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).